South Plains Financial, Inc. (SPFI) Stock Price & Analysis

South Plains Financial, Inc. (SPFI) rose 0.86% to USD 44.63 as of July 25, 2026 at 06:39 UTC, according to Nexqual real-time market data.

SPFI last closed at USD 44.25; the session ranged USD 43.75–45.19 on volume of 116,095 shares. Market capitalization is $840.79M, with a 52-week range of USD 35.34–46.94 (NMS). Source: Nexqual, July 25, 2026 at 06:39 UTC.

Key Statistics (as of July 25, 2026 at 06:39 UTC)

PriceUSD 44.63
Change▲ 0.86% (up)
Previous CloseUSD 44.25
OpenUSD 44.47
Day RangeUSD 43.75 – 45.19
52-Week RangeUSD 35.34 – 46.94
Volume116,095 shares
Market Cap$840.79M
ExchangeNMS

Technical Analysis (SPFI)

Nexqual's technical model rates SPFI "STRONG BUY" based on 5 bullish and 0 bearish signals across 125 daily candles, as of July 25, 2026 at 06:39 UTC.

Overall SignalSTRONG BUY
RSI (14)59.94 (neutral)
vs SMA50Above (USD 41.82)
MACD0.69 (positive)

Analyst Ratings (SPFI)

Wall Street analysts rate SPFI "Buy" based on 4 analysts, with a mean price target of USD 50.75 (range USD 50–53), per Nexqual as of July 25, 2026 at 06:39 UTC.

Consensus RatingBuy
Analyst Count4
Mean TargetUSD 50.75
High TargetUSD 53
Low TargetUSD 50
Buy / Hold / Sell4 / 0 / 0

Earnings (SPFI)

Next Earnings Date2026-10-22
EPS EstimateUSD 0.99
Revenue Estimate$65.22M

Recent Earnings History

QuarterActual vs Estimate
2026-06-30USD 1 vs est 0.94 ▲ beat
2026-03-31USD 0.85 vs est 0.88 ▼ miss
2025-12-31USD 0.9 vs est 0.88 ▲ beat
2025-09-30USD 0.96 vs est 0.86 ▲ beat

Source: Nexqual, July 25, 2026 at 06:39 UTC.

Financials & Fundamentals (SPFI)

Total Revenue$223.82M
Revenue Growth (YoY)+23.00%
Gross Margin+0.00%
Operating Margin+37.85%
Profit Margin+29.09%
ROE+12.02%
Total Cash$787.76M
Total Debt$60.49M

Source: Nexqual, July 25, 2026 at 06:39 UTC.

Financial Health Score (SPFI)

Nexqual rates South Plains Financial, Inc.'s overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 06:39 UTC.

GrowthSolid — Revenue +9% YoY (annual)
ProfitabilityCritical — Gross margin 0%
Balance SheetMixed — $788M cash vs $60M debt, net cash position
Cash FlowMixed — No data
EfficiencyMixed — ROE 12%, ROA 1.3%

Ownership (SPFI)

Insider Ownership+16.67%
Institutional Ownership+40.87%
Shares Outstanding18.84M
Float14.79M
Short % of Float+3.48%

Source: Nexqual, July 25, 2026 at 06:39 UTC.

Leadership (SPFI)

South Plains Financial, Inc. is led by Curtis C. Griffith (age 72), Chairman & CEO, per Nexqual as of July 25, 2026 at 06:39 UTC.

Chairman & CEOCurtis C. Griffith (age 72)
Executive VP, COO & DirectorCory T. Newsom (age 57)
CFO & TreasurerSteven B. Crockett (age 53)
Senior VP of City Bank & COO of City BankPaul A. Ehlers (age 54)
President of Windmark Insurance & Senior VP of Insurance Development of City BankKelly L. Deterding (age 66)

Major Backers & Investors (SPFI)

Notable institutional backers of South Plains Financial, Inc. include American Century Companies Inc, Acadian Asset Management. LLC, JPMorgan, according to Nexqual as of July 25, 2026 at 06:39 UTC.

Active Investors

InvestorStake
American Century Companies Inc4.15%
Acadian Asset Management. LLC2.57%
JPMorgan2.54%
Two Sigma Investments, LP0.91%
Bridgeway Capital Management, LLC0.86%

Index Funds (Passive)

FundStake
BlackRock8.17%
Vanguard Group5.78%
State Street2.96%
Dimensional Fund Advisors2.27%
Geode Capital1.53%

Source: Nexqual, July 25, 2026 at 06:39 UTC.

From South Plains Financial, Inc.'s Latest SEC 10-K Filing (filed 2026-03-05)

Key Strengths & Strategy (as disclosed to the SEC)

Partnerships

Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.

Peers & Related Stocks

SymbolNamePriceChange
RRBIRed River Bancshares, Inc.USD 99.49▲ 2.94%
MCBSMetroCity Bankshares, Inc.USD 36.57▲ 1.75%
RBBRBB BancorpUSD 26.28▼ 0.64%
SMBKSmartFinancial, Inc.USD 50.01▲ 3.11%
HBTHBT Financial, Inc.USD 33.29▲ 2.81%

Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 06:39 UTC. This page is informational and not investment advice.